![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Encore Wire Corporation | NASDAQ:WIRE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 289.84 | 265.06 | 289.85 | 0 | 01:00:00 |
FORM 10-K | ||
☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
ENCORE WIRE CORPORATION (Exact name of registrant as specified in its charter) | ||
Delaware | 75-2274963 | ||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||
1329 Millwood Road | |||||||||||
McKinney, | Texas | 75069 | |||||||||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, par value $.01 per share | WIRE | The NASDAQ Global Select Market |
PAGE | |||||
Item 6. [Reserved] | |||||
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | |||||
Name | Age | Position with Company | |||||||||
Daniel L. Jones | 59 | Chairman of the Board of Directors, President and Chief Executive Officer | |||||||||
Bret J. Eckert | 56 | Executive Vice President and Chief Financial Officer |
As of December 31, | |||||||||||||||||||||||
Total Return For: | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |||||||||||||||||
Encore Wire Corporation | $ | 100.00 | $ | 103.31 | $ | 118.35 | $ | 125.14 | $ | 295.88 | $ | 284.58 | |||||||||||
Russell 2000 Index | 100.00 | 88.99 | 111.70 | 134.00 | 153.85 | 122.41 | |||||||||||||||||
Peer Group | 100.00 | 61.70 | 88.27 | 112.78 | 148.95 | 143.67 | |||||||||||||||||
Prior Peer Group | 100.00 | 63.84 | 94.55 | 98.08 | 166.07 | 158.45 | |||||||||||||||||
October 2022 | November 2022 | December 2022 | Quarter Ended Dec. 31, 2022 | Year-to-Date Dec. 31, 2022 | |||||||||||||||||||||||||
High | $ | 3.63 | $ | 3.95 | $ | 3.88 | $ | 3.95 | $ | 4.93 | |||||||||||||||||||
Low | 3.36 | 3.46 | 3.75 | 3.36 | 3.21 | ||||||||||||||||||||||||
Average | 3.47 | 3.68 | 3.82 | 3.66 | 4.00 |
October 2021 | November 2021 | December 2021 | Quarter Ended Dec. 31, 2021 | Year-to-Date Dec. 31, 2021 | |||||||||||||||||||||||||
High | $ | 4.76 | $ | 4.46 | $ | 4.47 | $ | 4.76 | $ | 4.78 | |||||||||||||||||||
Low | 4.16 | 4.27 | 4.18 | 4.16 | 3.54 | ||||||||||||||||||||||||
Average | 4.45 | 4.37 | 4.33 | 4.38 | 4.25 |
October 2020 | November 2020 | December 2020 | Quarter Ended Dec. 31, 2020 | Year-to-Date Dec. 31, 2020 | |||||||||||||||||||||||||
High | $ | 3.19 | $ | 3.42 | $ | 3.63 | $ | 3.63 | $ | 3.63 | |||||||||||||||||||
Low | 2.86 | 3.07 | 3.47 | 2.86 | 2.12 | ||||||||||||||||||||||||
Average | 3.06 | 3.20 | 3.53 | 3.27 | 2.80 |
Quarter Ended March 31, 2022 | Quarter Ended June 30, 2022 | Quarter Ended Sept. 30, 2022 | Quarter Ended Dec. 31, 2022 | Year-to-Date Dec. 31, 2022 | |||||||||||||||||||||||||
High | $ | 4.93 | $ | 4.80 | $ | 3.71 | $ | 3.95 | $ | 4.93 | |||||||||||||||||||
Low | 4.30 | 3.71 | 3.21 | 3.36 | 3.21 | ||||||||||||||||||||||||
Average | 4.55 | 4.33 | 3.50 | 3.66 | 4.00 |
Quarter Ended March 31, 2021 | Quarter Ended June 30, 2021 | Quarter Ended Sept. 30, 2021 | Quarter Ended Dec. 31, 2021 | Year-to-Date Dec. 31, 2021 | |||||||||||||||||||||||||
High | $ | 4.30 | $ | 4.78 | $ | 4.59 | $ | 4.76 | $ | 4.78 | |||||||||||||||||||
Low | 3.54 | 4.00 | 4.04 | 4.16 | 3.54 | ||||||||||||||||||||||||
Average | 3.87 | 4.42 | 4.30 | 4.38 | 4.25 |
Year Ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
Net sales | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||||
Cost of goods sold: | |||||||||||||||||
Copper | 44.0 | % | 46.7 | % | 57.3 | % | |||||||||||
Other raw materials | 12.0 | % | 10.5 | % | 13.5 | % | |||||||||||
Depreciation | 0.8 | % | 0.8 | % | 1.4 | % | |||||||||||
Labor and overhead | 6.9 | % | 6.6 | % | 10.8 | % | |||||||||||
LIFO adjustment | (0.6) | % | 1.9 | % | 1.8 | % | |||||||||||
Total cost of goods sold | 63.1 | % | 66.5 | % | 84.8 | % | |||||||||||
Gross profit | 36.9 | % | 33.5 | % | 15.2 | % | |||||||||||
Selling, general and administrative expenses | 6.5 | % | 6.5 | % | 7.6 | % | |||||||||||
Operating income | 30.4 | % | 27.0 | % | 7.6 | % | |||||||||||
Net interest and other income | 0.3 | % | — | % | 0.1 | % | |||||||||||
Income before income taxes | 30.7 | % | 27.0 | % | 7.7 | % | |||||||||||
Provision for income taxes | 6.9 | % | 6.1 | % | 1.8 | % | |||||||||||
Net income | 23.8 | % | 20.9 | % | 5.9 | % |
2022 | 2021 | 2020 | |||||||||||||||
Raw materials | $ | 69,567 | $ | 54,012 | $ | 40,842 | |||||||||||
Work-in-process | 42,611 | 40,422 | 30,311 | ||||||||||||||
Finished goods | 138,943 | 123,401 | 88,544 | ||||||||||||||
Total | 251,121 | 217,835 | 159,697 | ||||||||||||||
Adjust to LIFO cost | (97,934) | (117,019) | (67,375) | ||||||||||||||
Inventory | $ | 153,187 | $ | 100,816 | $ | 92,322 |
Year Ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
Net cash provided by operating activities | $ | 688,883 | $ | 418,418 | $ | 57,462 | |||||||||||
Net cash used in investing activities | (148,350) | (118,155) | (85,991) | ||||||||||||||
Net cash used in financing activities | (248,966) | (44,396) | (19,313) | ||||||||||||||
Net increase in cash and cash equivalents | $ | 291,567 | $ | 255,867 | $ | (47,842) | |||||||||||
Annual dividends paid | $ | (1,548) | $ | (1,633) | $ | (1,650) |
Valuation of inventories | ||||||||
Description of the Matter | At December 31, 2022, the Company’s inventory balance was $153.2 million. As discussed in Notes 1 and 2 to the financial statements, inventories are stated at the lower of cost, using the last-in, first-out (LIFO) method, or market. The Company maintains two inventory pools for LIFO purposes. As permitted by U.S. generally accepted accounting principles, the Company maintains its inventory costs and cost of goods sold on a first-in, first-out (FIFO) basis and adjusts total inventory and cost of goods sold from FIFO to LIFO at each month end. Auditing management’s calculations to adjust the FIFO inventory balances to LIFO was challenging due to the complexities of the manual calculations. | |||||||
How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s calculations of the adjustments to convert FIFO inventory balances to LIFO, including controls over management’s review of the manual calculations described above. To test the LIFO inventory balance, we performed audit procedures that included, among others, assessing methodologies and testing the underlying data used in the Company’s calculations to adjust the FIFO inventory balances to LIFO. We also tested the mathematical accuracy of the Company’s calculations. |
2022 | 2021 | ||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 730,557 | $ | 438,990 | |||||||
Accounts receivable, net of allowance of $3,800 and $3,800 | 498,762 | 491,126 | |||||||||
Inventories, net | 153,187 | 100,816 | |||||||||
Income taxes receivable | 15,143 | 951 | |||||||||
Prepaid expenses and other | 3,992 | 3,167 | |||||||||
Total current assets | 1,401,641 | 1,035,050 | |||||||||
Property, plant and equipment, net | 616,601 | 494,916 | |||||||||
Other assets | 490 | 570 | |||||||||
Total assets | $ | 2,018,732 | $ | 1,530,536 | |||||||
Liabilities and Stockholders’ Equity | |||||||||||
Current liabilities: | |||||||||||
Trade accounts payable | $ | 62,780 | $ | 75,353 | |||||||
Accrued liabilities | 81,381 | 78,747 | |||||||||
Total current liabilities | 144,161 | 154,100 | |||||||||
Deferred income taxes and other | 55,905 | 37,347 | |||||||||
Commitments and contingencies | |||||||||||
Stockholders’ equity: | |||||||||||
Preferred stock, $.01 par value: | |||||||||||
Authorized shares – 2,000,000; none issued | — | — | |||||||||
Common stock, $.01 par value: | |||||||||||
Authorized shares – 40,000,000; | |||||||||||
Issued shares – 27,139,611 and 27,083,100 | 271 | 271 | |||||||||
Additional paid-in capital | 83,622 | 72,753 | |||||||||
Treasury stock, at cost – 8,999,732 and 6,944,262 shares | (402,639) | (155,014) | |||||||||
Retained earnings | 2,137,412 | 1,421,079 | |||||||||
Total stockholders’ equity | 1,818,666 | 1,339,089 | |||||||||
Total liabilities and stockholders’ equity | $ | 2,018,732 | $ | 1,530,536 |
2022 | 2021 | 2020 | |||||||||||||||
Net sales | $ | 3,017,555 | $ | 2,592,721 | $ | 1,276,948 | |||||||||||
Cost of goods sold | 1,905,134 | 1,724,975 | 1,082,413 | ||||||||||||||
Gross profit | 1,112,421 | 867,746 | 194,535 | ||||||||||||||
Selling, general and administrative expenses | 197,418 | 168,543 | 97,008 | ||||||||||||||
Operating income | 915,003 | 699,203 | 97,527 | ||||||||||||||
Net interest and other income | 9,847 | 194 | 1,269 | ||||||||||||||
Income before income taxes | 924,850 | 699,397 | 98,796 | ||||||||||||||
Provision for income taxes | 207,009 | 157,975 | 22,729 | ||||||||||||||
Net income | $ | 717,841 | $ | 541,422 | $ | 76,067 | |||||||||||
Earnings per common and common equivalent share – basic | $ | 37.47 | $ | 26.49 | $ | 3.69 | |||||||||||
Earnings per common and common equivalent share – diluted | $ | 36.91 | $ | 26.22 | $ | 3.68 | |||||||||||
Weighted average common and common equivalent shares outstanding – basic | 19,159 | 20,439 | 20,599 | ||||||||||||||
Weighted average common and common equivalent shares outstanding – diluted | 19,446 | 20,649 | 20,653 | ||||||||||||||
Cash dividends declared per share | $ | 0.08 | $ | 0.08 | $ | 0.08 |
Common Stock | Additional Paid-In Capital | Treasury Stock | Retained Earnings | ||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Total | |||||||||||||||||||||||||||||||||||||
Balance at January 1, 2020 | 26,939 | $ | 269 | $ | 63,009 | (6,027) | $ | (91,056) | $ | 806,874 | $ | 779,096 | |||||||||||||||||||||||||||||
Net income | — | — | — | — | — | 76,067 | 76,067 | ||||||||||||||||||||||||||||||||||
Exercise of stock options | 69 | 1 | 2,998 | — | — | — | 2,999 | ||||||||||||||||||||||||||||||||||
Stock-based compensation | 17 | — | 1,878 | — | — | — | 1,878 | ||||||||||||||||||||||||||||||||||
Dividend declared—$0.08 per share | — | — | — | — | — | (1,649) | (1,649) | ||||||||||||||||||||||||||||||||||
Purchase of treasury stock | — | — | — | (441) | (20,662) | — | (20,662) | ||||||||||||||||||||||||||||||||||
Balance at December 31, 2020 | 27,025 | 270 | 67,885 | (6,468) | (111,718) | 881,292 | 837,729 | ||||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | 541,422 | 541,422 | ||||||||||||||||||||||||||||||||||
Exercise of stock options | 35 | 1 | 1,083 | — | — | — | 1,084 | ||||||||||||||||||||||||||||||||||
Stock-based compensation | 23 | — | 3,785 | — | — | — | 3,785 | ||||||||||||||||||||||||||||||||||
Dividend declared—$0.08 per share | — | — | — | — | — | (1,635) | (1,635) | ||||||||||||||||||||||||||||||||||
Purchase of treasury stock | — | — | — | (476) | (43,296) | — | (43,296) | ||||||||||||||||||||||||||||||||||
Balance at December 31, 2021 | 27,083 | 271 | 72,753 | (6,944) | (155,014) | 1,421,079 | 1,339,089 | ||||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | 717,841 | 717,841 | ||||||||||||||||||||||||||||||||||
Exercise of stock options | 4 | — | 207 | — | — | — | 207 | ||||||||||||||||||||||||||||||||||
Stock-based compensation | 52 | — | 10,662 | — | — | — | 10,662 | ||||||||||||||||||||||||||||||||||
Dividend declared—$0.08 per share | — | — | — | — | — | (1,508) | (1,508) | ||||||||||||||||||||||||||||||||||
Purchase of treasury stock | — | — | — | (2,056) | (247,625) | — | (247,625) | ||||||||||||||||||||||||||||||||||
Balance at December 31, 2022 | 27,139 | $ | 271 | $ | 83,622 | (9,000) | $ | (402,639) | $ | 2,137,412 | $ | 1,818,666 |
2022 | 2021 | 2020 | |||||||||||||||
Operating Activities | |||||||||||||||||
Net income | $ | 717,841 | $ | 541,422 | $ | 76,067 | |||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
Depreciation and amortization | 26,232 | 23,288 | 19,459 | ||||||||||||||
Deferred income taxes | 19,539 | 2,264 | 6,429 | ||||||||||||||
Stock-based compensation attributable to equity awards | 10,662 | 3,786 | 1,878 | ||||||||||||||
Other | 1,796 | 5,831 | 470 | ||||||||||||||
Changes in operating assets and liabilities: | |||||||||||||||||
Accounts receivable | (7,636) | (216,808) | (53,383) | ||||||||||||||
Inventories | (52,371) | (8,494) | (2,638) | ||||||||||||||
Other assets | (980) | (62) | (746) | ||||||||||||||
Trade accounts payable and accrued liabilities | (12,008) | 66,886 | 7,580 | ||||||||||||||
Current income taxes receivable / payable | (14,192) | 305 | 2,346 | ||||||||||||||
Net cash provided by operating activities | 688,883 | 418,418 | 57,462 | ||||||||||||||
Investing Activities | |||||||||||||||||
Purchases of property, plant and equipment | (148,350) | (118,252) | (86,082) | ||||||||||||||
Proceeds from sale of assets | — | 97 | 91 | ||||||||||||||
Net cash used in investing activities | (148,350) | (118,155) | (85,991) | ||||||||||||||
Financing Activities | |||||||||||||||||
Deferred financing fees | — | (550) | — | ||||||||||||||
Purchase of treasury stock | (247,625) | (43,296) | (20,662) | ||||||||||||||
Proceeds from issuance of common stock, net | 207 | 1,083 | 2,999 | ||||||||||||||
Dividends paid | (1,548) | (1,633) | (1,650) | ||||||||||||||
Net cash used in financing activities | (248,966) | (44,396) | (19,313) | ||||||||||||||
Net increase (decrease) in cash and cash equivalents | 291,567 | 255,867 | (47,842) | ||||||||||||||
Cash and cash equivalents at beginning of period | 438,990 | 183,123 | 230,965 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 730,557 | $ | 438,990 | $ | 183,123 |
Allowance for Credit Losses (In Thousands) | 2022 | 2021 | 2020 | ||||||||||||||
Beginning balance January 1 | $ | 3,800 | $ | 2,215 | $ | 1,801 | |||||||||||
Write-offs of bad debts | — | — | (286) | ||||||||||||||
Collection of previous write-offs | — | 122 | — | ||||||||||||||
Adjustment to allowance for credit losses | — | 1,463 | 700 | ||||||||||||||
Ending balance at December 31 | $ | 3,800 | $ | 3,800 | $ | 2,215 |
In Thousands | 2022 | 2021 | |||||||||
Raw materials | $ | 69,567 | $ | 54,012 | |||||||
Work-in-process | 42,611 | 40,422 | |||||||||
Finished goods | 138,943 | 123,401 | |||||||||
Total | 251,121 | 217,835 | |||||||||
Adjust to LIFO cost | (97,934) | (117,019) | |||||||||
Inventory, net | $ | 153,187 | $ | 100,816 |
In Thousands | 2022 | 2021 | |||||||||
Land and land improvements | $ | 85,286 | $ | 72,897 | |||||||
Construction-in-progress | 125,809 | 92,414 | |||||||||
Buildings and improvements | 232,758 | 217,985 | |||||||||
Machinery and equipment | 438,303 | 362,996 | |||||||||
Furniture and fixtures | 15,178 | 13,805 | |||||||||
Property, plant and equipment, gross | 897,334 | 760,097 | |||||||||
Accumulated depreciation | (280,733) | (265,181) | |||||||||
Property, plant and equipment, net | $ | 616,601 | $ | 494,916 |
In Thousands | 2022 | 2021 | |||||||||
Sales rebates payable | $ | 40,909 | $ | 40,657 | |||||||
Stock Appreciation Rights (SAR) Liability | 20,282 | 22,095 | |||||||||
Property taxes payable | 5,287 | 5,018 | |||||||||
Accrued salaries | 7,616 | 4,778 | |||||||||
Other accrued liabilities | 7,287 | 6,199 | |||||||||
Total accrued liabilities | $ | 81,381 | $ | 78,747 |
In Thousands | 2022 | 2021 | 2020 | ||||||||||||||
Current: | |||||||||||||||||
Federal | $ | 175,090 | $ | 143,392 | $ | 14,277 | |||||||||||
State | 12,379 | 12,319 | 2,024 | ||||||||||||||
Deferred: | |||||||||||||||||
Federal | 19,797 | 2,132 | 6,285 | ||||||||||||||
State | (257) | 132 | 143 | ||||||||||||||
Total income tax expense | $ | 207,009 | $ | 157,975 | $ | 22,729 |
In Thousands | 2022 | 2021 | 2020 | ||||||||||||||
Amount computed using the statutory rate | $ | 194,218 | $ | 146,873 | $ | 20,747 | |||||||||||
State income taxes, net of federal tax benefit | 9,576 | 9,836 | 1,732 | ||||||||||||||
Other | 3,215 | 1,266 | 250 | ||||||||||||||
Total income tax expense | $ | 207,009 | $ | 157,975 | $ | 22,729 |
In Thousands | 2022 | 2021 | |||||||||
Depreciation | $ | (60,304) | $ | (42,966) | |||||||
Inventory | (2,080) | 423 | |||||||||
Allowance for credit losses | 843 | 856 | |||||||||
Uniform capitalization rules | 574 | 729 | |||||||||
Stock-based compensation | 4,791 | 5,032 | |||||||||
Other | 536 | (175) | |||||||||
Net deferred income tax liability | $ | (55,640) | $ | (36,101) |
In Thousands | 2022 | 2021 | 2020 | ||||||||||||||
Restricted Stock Units | $ | 9,054 | $ | 1,889 | $ | — | |||||||||||
Stock grants | 724 | 489 | 244 | ||||||||||||||
Stock options | 289 | 435 | 561 | ||||||||||||||
Stock appreciation rights (“SARs”) | 7,319 | 22,188 | 3,377 | ||||||||||||||
Restricted Stock Awards | 1,005 | 1,005 | 1,101 | ||||||||||||||
Total stock-based compensation expense | $ | 18,391 | $ | 26,006 | $ | 5,283 |
Weighted Average | ||||||||
Number of Units | Grant Date Fair Value | |||||||
Outstanding at January 1, 2022 | 98,600 | $ | 61.92 | |||||
Granted | 177,200 | 127.58 | ||||||
Vested | (32,864) | 61.92 | ||||||
Forfeited/Canceled | (1,500) | 128.69 | ||||||
Unvested at December 31, 2022 | 241,436 | $ | 109.69 |
Number of Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value (In Thousands) | ||||||||||||||||||||
Outstanding at January 1, 2022 | 279,500 | $ | 43.18 | ||||||||||||||||||||
Exercised | (4,000) | 51.63 | |||||||||||||||||||||
Forfeited/Canceled | — | — | |||||||||||||||||||||
Outstanding at December 31, 2022 | 275,500 | $ | 43.06 | 3.6 years | $ | 26,036 | |||||||||||||||||
Vested and exercisable at December 31, 2022 | 258,000 | $ | 42.51 | 3.5 years | $ | 24,522 |
Cash-settled SARs | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value (In Thousands) | ||||||||||||||||||||
Outstanding at January 1, 2022 | 467,668 | $ | 53.55 | ||||||||||||||||||||
Exercised | (113,904) | 51.13 | |||||||||||||||||||||
Forfeited/Canceled | (21,600) | 56.66 | |||||||||||||||||||||
Outstanding at December 31, 2022 | 332,164 | $ | 54.18 | 6.2 years | $ | 27,696 | |||||||||||||||||
Vested and exercisable at December 31, 2022 | 117,664 | $ | 52.07 | 5.8 years | $ | 10,059 |
Year Ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
Risk-free interest rate | 4.46 | % | 0.70 | % | 0.18 | % | |||||||||||
Expected dividend yield | 0.06 | % | 0.06 | % | 0.13 | % | |||||||||||
Expected volatility | 44.03 | % | 38.64 | % | 35.51 | % | |||||||||||
Expected lives | 1.3 years | 2.1 years | 2.8 years |
Weighted Average | ||||||||
Number of Shares | Grant Date Fair Value | |||||||
Outstanding at January 1, 2022 | 58,000 | $ | 56.88 | |||||
Granted | — | — | ||||||
Vested | (17,000) | 56.61 | ||||||
Unvested at December 31, 2022 | 41,000 | $ | 57.00 |
In Thousands | 2022 | 2021 | 2020 | ||||||||||||||
Numerator: | |||||||||||||||||
Net income | $ | 717,841 | $ | 541,422 | $ | 76,067 | |||||||||||
Denominator: | |||||||||||||||||
Denominator for basic earnings per share – weighted average shares | 19,159 | 20,439 | 20,599 | ||||||||||||||
Effect of dilutive securities: | |||||||||||||||||
Employee stock awards | 287 | 210 | 54 | ||||||||||||||
Denominator for diluted earnings per share – weighted average shares | 19,446 | 20,649 | 20,653 |
In Thousands, Except Per Share Data | 2022 | 2021 | 2020 | ||||||||||||||
Weighted average anti-dilutive stock options | — | — | 136 | ||||||||||||||
Weighted average exercise price per share | $ | — | $ | — | $ | 51.20 |
Three Months Ended | |||||||||||||||||||||||
2022 | March 31 | June 30 | September 30 | December 31 | |||||||||||||||||||
Net sales | $ | 723,072 | $ | 838,235 | $ | 762,363 | $ | 693,885 | |||||||||||||||
Gross profit | 243,747 | 320,772 | 299,447 | 248,455 | |||||||||||||||||||
Net income | 161,531 | 210,538 | 191,773 | 153,998 | |||||||||||||||||||
Earnings per common share – basic | 8.08 | 10.84 | 10.11 | 8.43 | |||||||||||||||||||
Earnings per common share – diluted | 7.96 | 10.71 | 9.97 | 8.28 |
Three Months Ended | |||||||||||||||||||||||
2021 | March 31 | June 30 | September 30 | December 31 | |||||||||||||||||||
Net sales | $ | 444,140 | $ | 744,408 | $ | 716,320 | $ | 687,853 | |||||||||||||||
Gross profit | 84,504 | 277,342 | 270,766 | 235,134 | |||||||||||||||||||
Net income | 41,189 | 183,053 | 175,538 | 141,642 | |||||||||||||||||||
Earnings per common share – basic | 2.00 | 8.89 | 8.60 | 7.02 | |||||||||||||||||||
Earnings per common share – diluted | 1.99 | 8.82 | 8.51 | 6.91 |
Number of securities to be issued upon exercise of outstanding options, warrants and rights | Weighted-average exercise price of outstanding options, warrants and rights | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) | ||||||||||||||||||
PLAN CATEGORY | (a) | (b) | (c) | |||||||||||||||||
Equity compensation plans approved by security holders (1) | 275,500 | $ | 43.06 | (2) | 706,600 | (3) |
Exhibit Number | Description | |||||||
3.1 | ||||||||
3.2 | ||||||||
4.1 | Form of certificate for Common Stock (filed as Exhibit 1 to the Company’s registration statement on Form 8-A, filed with the SEC on June 4, 1992 and incorporated herein by reference). | |||||||
4.2 | ||||||||
10.1* | ||||||||
10.2* | ||||||||
10.3* | ||||||||
10.4* | ||||||||
10.5* | ||||||||
10.6* | ||||||||
10.7* | ||||||||
10.8* | ||||||||
10.9* | ||||||||
10.10 | ||||||||
10.11 | ||||||||
10.12* | ||||||||
23.1 | ||||||||
31.1 | ||||||||
31.2 | ||||||||
32.1 | ||||||||
32.2 | ||||||||
101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Document | |||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
104 | Cover Page Interactive Data File - formatted as Inline XBRL and contained in Exhibit 101 |
Date: February 16, 2023 | ENCORE WIRE CORPORATION | ||||||||||
By: | /s/ Daniel L. Jones | ||||||||||
Daniel L. Jones Chairman, President and Chief Executive Officer |
Signature | Title | Date | ||||||||||||
/s/ DANIEL L. JONES | Chairman, President and Chief Executive Officer (Principal Executive Officer) | February 16, 2023 | ||||||||||||
Daniel L. Jones | ||||||||||||||
/s/ BRET J. ECKERT | Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) | February 16, 2023 | ||||||||||||
Bret J. Eckert | ||||||||||||||
/s/ GINA A. NORRIS | Director | February 16, 2023 | ||||||||||||
Gina A. Norris | ||||||||||||||
/s/ WILLIAM R. THOMAS | Director | February 16, 2023 | ||||||||||||
William R. Thomas | ||||||||||||||
/s/ W. KELVIN WALKER | Director | February 16, 2023 | ||||||||||||
W. Kelvin Walker | ||||||||||||||
/s/ SCOTT D. WEAVER | Director | February 16, 2023 | ||||||||||||
Scott D. Weaver | ||||||||||||||
/s/ JOHN H. WILSON | Lead Independent Director | February 16, 2023 | ||||||||||||
John H. Wilson |
1 Year Encore Wire Chart |
1 Month Encore Wire Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions